Inventage Lab Inc.
Biopharmaceutical company developing advanced drug delivery systems.
389470 | KO
Overview
Corporate Details
- ISIN(s):
- KR7389470006
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 둔촌대로388번길 24, 101호, 601호, 612호, 성남시
Description
Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-07-03 00:00 |
전환청구권행사 (제1회차)
|
Korean | 9.6 KB | ||
| 2024-07-01 00:00 |
기타경영사항(자율공시) (전환우선주의 보통주 전환청구)
|
Korean | 8.9 KB | ||
| 2024-05-20 00:00 |
투자판단관련주요경영사항 (IVL3013 독점적 라이선스 아웃 계약관련 마일스톤 기술료 수령)
|
Korean | 7.6 KB | ||
| 2024-05-16 00:00 |
분기보고서 (2024.03)
|
Korean | 1.0 MB | ||
| 2024-03-28 00:00 |
정기주주총회결과
|
Korean | 23.2 KB | ||
| 2024-03-21 00:00 |
[기재정정]파생상품거래손실발생
|
Korean | 13.2 KB | ||
| 2024-03-20 00:00 |
감사보고서제출
|
Korean | 18.2 KB | ||
| 2024-03-20 00:00 |
사업보고서 (2023.12)
|
Korean | 347.7 KB | ||
| 2024-03-18 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인) (알코올 의존성 및 opioid 의존성 치료제(IVL3004) 및 다발성 …
|
Korean | 11.5 KB | ||
| 2024-03-13 00:00 |
주주총회소집공고
|
Korean | 116.9 KB | ||
| 2024-03-12 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 12.1 KB | ||
| 2024-03-12 00:00 |
주주총회소집결의
|
Korean | 12.5 KB | ||
| 2024-02-21 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청) (알코올 의존성 및 opioid 의존성 치료제(IVL3004) 및 다발…
|
Korean | 10.5 KB | ||
| 2024-02-05 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 153.2 KB | ||
| 2024-02-05 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.2 KB |
Automate Your Workflow. Get a real-time feed of all Inventage Lab Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inventage Lab Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inventage Lab Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
